Clinical trial aims to prevent Alzheimer's disease
There are new clinical trials for a vaccine that prevents Alzheimer's.
Only one person has gotten the vaccine. Nancy Roderick first took a genetic test to check how high her risk is for Alzheimer's.
The vaccine reduces the amyloid protein. If it builds up, it can affect the brain and trigger Alzheimer's disease.
This prevention trial is for healthy men and women between the ages of 60 and 75, who are at higher risk but have normal memory.
"This is a double blind study," said Dr. Stephen Salloway of Butler Hospital's Memory and Aging Program. "She has a two out of three chance of getting the active medicine."
Roderick will receive this vaccine every thirteen weeks and be followed for at least five years.